<div id="subtitle">FDA plan requires Amgen, J&J to educate doctors and patients on risks of anemia drugs</div><div><p>Amgen and Johnson & Johnson will be required to publicize the life-threatening risks of their anemia drugs, under the latest government-imposed safety precautions to snare the blockbuster ...

<div><p>WASHINGTON (Reuters) - U.S. regulators plan to ask outside experts to re-evaluate the use of Amgen Inc and Johnson & Johnson anemia drugs when given to patients with chronic kidney disease.</p><p>Food and Drug Administration officials, in an article published in the New England Journal of Medicine ...

<div><p>CHICAGO (Reuters) - Cancer patients who took drugs to cut the risk of anemia were twice as likely to develop blood clots in the lungs or legs as other patients, a decade-long study of more than 55,000 cancer patients has found.</p><p>The study adds to mounting evidence that ...

<div><p>NEW YORK (Reuters) - Johnson & Johnson <JNJ.N> posted weaker-than-expected quarterly revenue on Tuesday as sales of prescription drugs and heart stents disappointed, sending its shares down 2.4 percent.</p><p>While third-quarter profit topped analyst forecasts, that was largely because of cost cuts ...